Artikel

Development and Recent Advances in SLIPT‐PM: A Chemogenetic Platform for Manipulating Signaling at the Plasma Membrane

28.07.2025

Von Wiley-VCH zur Verfügung gestellt

SLIPT-PM enables the translocation of tag-fused proteins from the cytoplasm to the plasma membrane using a synthetic self-localizing ligand. This user-friendly system permits reversible control of diverse signaling pathways. This concept article highlights the key features and current applications of SLIPT-PM as a powerful tool in chemical and synthetic biology.


Upon cell stimulation, mammalian cells activate various signaling proteins and lipids by recruiting their upstream regulators to the inner leaflet of the plasma membrane (PM), which in turn determines their cellular response. Therefore, artificially inducing protein translocation to the PM is an effective strategy for dissecting cell signaling networks and engineering cellular functions. Self-localizing ligand-induced protein translocation (SLIPT) is an emerging technique that we developed to control protein localization in living cells using synthetic self-localizing ligands (SLs). Building on this strategy, we recently introduced a versatile chemogenetic SLIPT platform that rapidly recruits proteins of interest fused to an engineered Escherichia coli dihydrofolate reductase tag from the cytoplasm to the PM using a trimethoprim-based SL. The PM-specific SLIPT (SLIPT-PM) system is easy to use and enables researchers to manipulate diverse intracellular signaling molecules and pathways with controlled reversibility and repeatability. Owing to its modular design, related SLIPT-PM tools have also been developed to support more sophisticated experiments, such as light-induced spatially regulated protein recruitment and multiplexed signal manipulation. In this concept article, we review the development, principal features, current applications, and future challenges of SLIPT-PM as a unique tool in chemical biology and synthetic biology.

Verwandte Artikel
Development and Recent Advances in SLIPT‐PM: A Chemogenetic Platform for Manipulating Signaling at the Plasma Membrane
In Kürze
Development and Recent Advances in SLIPT‐PM: A Chemogenetic Platform for Manipulating Signaling at the Plasma Membrane
Ehrungen, Karriere
Development and Recent Advances in SLIPT‐PM: A Chemogenetic Platform for Manipulating Signaling at the Plasma Membrane
Aus den Fachgruppen
Development and Recent Advances in SLIPT‐PM: A Chemogenetic Platform for Manipulating Signaling at the Plasma Membrane
EuChemS Policy Workshop „PFAS”
Development and Recent Advances in SLIPT‐PM: A Chemogenetic Platform for Manipulating Signaling at the Plasma Membrane
Bafög beantragen

Das könnte Sie auch interessieren

GDCh-Mitglieder exklusiv

Artikel • Nachrichten aus der Chemie

In Kürze

GÖCH

Termin vormerken: Generalversammlung am 21. September Die diesjährige Generalversammlung ist im Rahmen der Chemietage am...

30.04.2026
GDCh-Mitglieder exklusiv

Artikel • Nachrichten aus der Chemie

Ehrungen, Karriere

Service

Ehrungen Finnian Freeling, Dr.: Promotionspreis Wasserchemie der Wasserchemischen Gesellschaft, Fachgruppe der GDCh, für...

30.04.2026
GDCh-Mitglieder exklusiv

Artikel • Nachrichten aus der Chemie

Aus den Fachgruppen

GDCh

Bauchemie Neuer Vorstand Die GDCh-Fachgruppe Bauchemie hat ihren Vorstand für die Amtszeit 1. Januar 2026 bis 31. Dezemb...

30.04.2026